Iodine (131 I) derlotuximab biotin is a monoclonal antibody designed for the treatment of recurrent glioblastoma multiforme. This drug was developed by Peregrine Pharmaceuticals, Inc. This drug, under the brand name vivatuxin, has been approved for treatment of lung cancer in China since 2007.
References